Background Achieving polio eradication requires ensuring the delivery of sufficient supplies
of the right vaccines to the right places at the right times. Despite large global markets …

Introduction Detection of poliovirus transmission and ongoing oral poliovirus vaccine (OPV)
use continue to delay poliomyelitis eradication. In 2016, the Global Polio Eradication …

Abstract In 2019, the World Health Organization (WHO) named “Vaccine Hesitancy” one of
the top 10 threats to global health. Shortly afterward, the COVID‐19 pandemic emerged as …

Microbial diseases have become quite common in recent years. The interest in new
antimicrobial drugs is increasing due to the possible side effects of synthetic drugs and the …

Abstract In early 2020, the COVID-19 pandemic led to substantial disruptions in global
activities. The disruptions also included intentional and unintentional reductions in health …

Background To describe in chronological detail Pakistan's decades long battle against
poliovirus and evaluate the multiple factors impacting it. Main body Pakistan's fight is …

Despite exhaustive and fully-financed plans to manage the risks of globally coordinated
cessation of oral poliovirus vaccine (OPV) containing type 2 (OPV2) prior to 2016, as of …

Due to the very low, but nonzero, paralysis risks associated with the use of oral poliovirus
vaccine (OPV), eradicating poliomyelitis requires ending all OPV use globally. The Global …

Background Investments in national immunization programs and the Global Polio
Eradication Initiative (GPEI) have resulted in substantial reductions in paralytic polio …

Abstract In May 2016, the Global Polio Eradication Initiative (GPEI) coordinated the
cessation of all use of type 2 oral poliovirus vaccine (OPV2), except for emergency outbreak …